Search research articles
Contact Us
Filters
Showing results (201-210 of 313) with videos related to
Page
of 32
Sort By:
Cancers
|
April 27, 2024
Outcomes of Modified Mayo Stage IIIa and IIIb Cardiac Light-Chain Amyloidosis: Real-World Experience in Clinical Characteristics and Treatment-67 Patients Multicenter Analysis
Grzegorz Charliński, Maximilian Steinhardt, Leo Rasche, et al.
British Journal of Haematology
|
March 5, 2011
Bendamustine with or without rituximab in the treatment of relapsed chronic lymphocytic leukaemia: an Italian retrospective study
Emilio Iannitto, Fortunato Morabito, Salvatrice Mancuso, et al.
Scientific Reports
|
October 29, 2020
Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patients
Paola Monti, Marta Lionetti, Giuseppa De Luca, et al.
American Journal of Hematology
|
July 29, 2016
The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: Independent validation in a prospective cohort of early stage patients
Stefano Molica, Tait D Shanafelt, Diana Giannarelli, et al.
Nanoscale
|
February 10, 2022
A novel phage display based platform for exosome diversity characterization
Domenico Maisano, Selena Mimmi, Vincenzo Dattilo, et al.
Annals of Hematology
|
December 20, 2019
A comparative effectiveness study of lipegfilgrastim in multiple myeloma patients after high dose melphalan and autologous stem cell transplant
Massimo Martino, Mercedes Gori, Giovanni Tripepi, et al.
Annals of Hematology
|
April 21, 2018
Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practice
Massimo Breccia, Elisabetta Abruzzese, Fausto Castagnetti, et al.
British Journal of Haematology
|
February 18, 2020
Redefining the prognostic likelihood of chronic lymphocytic leukaemia patients with borderline percentage of immunoglobulin variable heavy chain region mutations
Sara Raponi, Caterina Ilari, Irene Della Starza, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 15, 2014
Long-term results in multiple myeloma after high-dose melphalan and autologous transplantation according to response categories in the era of old drugs
Massimo Martino, Maurizio Postorino, Giuseppe Alberto Gallo, et al.
Hematological Oncology
|
March 4, 2026
Clinical Outcomes in Double-Exposed Chronic Lymphocytic Leukemia Patients in Italy
Francesco Autore, Andrea Visentin, Candida Vitale, et al.
Page
of 32
Search research articles
Search
Showing results (201-210 of 313) with videos related to
Sort By:
Page
of 32
Cancers
|
April 27, 2024
Outcomes of Modified Mayo Stage IIIa and IIIb Cardiac Light-Chain Amyloidosis: Real-World Experience in Clinical Characteristics and Treatment-67 Patients Multicenter Analysis
Grzegorz Charliński, Maximilian Steinhardt, Leo Rasche, et al.
British Journal of Haematology
|
March 5, 2011
Bendamustine with or without rituximab in the treatment of relapsed chronic lymphocytic leukaemia: an Italian retrospective study
Emilio Iannitto, Fortunato Morabito, Salvatrice Mancuso, et al.
Scientific Reports
|
October 29, 2020
Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patients
Paola Monti, Marta Lionetti, Giuseppa De Luca, et al.
American Journal of Hematology
|
July 29, 2016
The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: Independent validation in a prospective cohort of early stage patients
Stefano Molica, Tait D Shanafelt, Diana Giannarelli, et al.
Nanoscale
|
February 10, 2022
A novel phage display based platform for exosome diversity characterization
Domenico Maisano, Selena Mimmi, Vincenzo Dattilo, et al.
Annals of Hematology
|
December 20, 2019
A comparative effectiveness study of lipegfilgrastim in multiple myeloma patients after high dose melphalan and autologous stem cell transplant
Massimo Martino, Mercedes Gori, Giovanni Tripepi, et al.
Annals of Hematology
|
April 21, 2018
Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practice
Massimo Breccia, Elisabetta Abruzzese, Fausto Castagnetti, et al.
British Journal of Haematology
|
February 18, 2020
Redefining the prognostic likelihood of chronic lymphocytic leukaemia patients with borderline percentage of immunoglobulin variable heavy chain region mutations
Sara Raponi, Caterina Ilari, Irene Della Starza, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 15, 2014
Long-term results in multiple myeloma after high-dose melphalan and autologous transplantation according to response categories in the era of old drugs
Massimo Martino, Maurizio Postorino, Giuseppe Alberto Gallo, et al.
Hematological Oncology
|
March 4, 2026
Clinical Outcomes in Double-Exposed Chronic Lymphocytic Leukemia Patients in Italy
Francesco Autore, Andrea Visentin, Candida Vitale, et al.
Page
of 32